Yang LY - Search Results

1

Evaluation of CI-973, a platinum analogue, in refractory or relapsed acute leukemia.

Kantarjian HM, Beran M, O'Brien S, Robertson L, Siddik Z, Yoshida M, Yang LY, Rios MB, Keating MJ, Meyer M, et al. Kantarjian HM, et al. Among authors: yang ly. Leukemia. 1996 Mar;10(3):396-401. Leukemia. 1996. PMID: 8642853 Clinical Trial.

2

Fludarabine--present status and future developments in chronic lymphocytic leukemia and lymphoma.

Keating MJ, McLaughlin P, Plunkett W, Robertson LE, O'Brien S, Gandhi V, Gregoire V, Yang L, Cabanillas F. Keating MJ, et al. Ann Oncol. 1994;5 Suppl 2:79-83. doi: 10.1093/annonc/5.suppl_2.s79. Ann Oncol. 1994. PMID: 8204523 Review.

3

DNA cross-linking and repair in Cisplatin-resistant human tumor-cells following exposure to a new Cisplatin analog, ci-973.

Yang L, Liu Y, Li L, Kantarjian H, Keating M. Yang L, et al. Int J Oncol. 1994 Sep;5(3):597-602. doi: 10.3892/ijo.5.3.597. Int J Oncol. 1994. PMID: 21559619

4

Fludarabine-mediated repair inhibition of cisplatin-induced DNA lesions in human chronic myelogenous leukemia-blast crisis K562 cells: induction of synergistic cytotoxicity independent of reversal of apoptosis resistance.

Li L, Keating MJ, Plunkett W, Yang LY. Li L, et al. Among authors: yang ly. Mol Pharmacol. 1997 Nov;52(5):798-806. doi: 10.1124/mol.52.5.798. Mol Pharmacol. 1997. PMID: 9351970

5

New initiatives with fludarabine monophosphate in hematologic malignancies.

Keating MJ, O'Brien S, Robertson LE, Kantarjian H, Dimopoulos M, McLaughlin P, Cabanillas F, Gregoire V, Yang LY, Gandhi V, et al. Keating MJ, et al. Among authors: yang ly. Semin Oncol. 1993 Oct;20(5 Suppl 7):13-20. Semin Oncol. 1993. PMID: 7694371 Review.

6

Arabinosyl-2-fluoroadenine augments cisplatin cytotoxicity and inhibits cisplatin-DNA cross-link repair.

Yang LY, Li L, Keating MJ, Plunkett W. Yang LY, et al. Mol Pharmacol. 1995 May;47(5):1072-9. Mol Pharmacol. 1995. PMID: 7746274

7

Fludarabine triphosphate inhibits nucleotide excision repair of cisplatin-induced DNA adducts in vitro.

Li L, Liu X, Glassman AB, Keating MJ, Stros M, Plunkett W, Yang LY. Li L, et al. Among authors: yang ly. Cancer Res. 1997 Apr 15;57(8):1487-94. Cancer Res. 1997. PMID: 9108450

8

Fludarabine: pharmacokinetics, mechanisms of action, and rationales for combination therapies.

Plunkett W, Gandhi V, Huang P, Robertson LE, Yang LY, Gregoire V, Estey E, Keating MJ. Plunkett W, et al. Among authors: yang ly. Semin Oncol. 1993 Oct;20(5 Suppl 7):2-12. Semin Oncol. 1993. PMID: 8235690 Review.

9

Distinct P-glycoprotein expression in two subclones simultaneously selected from a human colon carcinoma cell line by cis-diamminedichloroplatinum (II).

Yang LY, Trujillo JM, Siciliano MJ, Kido Y, Siddik ZH, Su YZ. Yang LY, et al. Int J Cancer. 1993 Feb 1;53(3):478-85. doi: 10.1002/ijc.2910530321. Int J Cancer. 1993. PMID: 8094074

10

Increased cytotoxicity and reversal of resistance to cis-diamminedichloro-platinum(II) with entrapment of cis-Bis-neodecanoato-trans-R,R-1,2-diaminocyclohexaneplatinum (II) in multilamellar lipid vesicles.

Perez-Soler R, Yang LY, Drewinko B, Lauterzstain J, Khokhar AR. Perez-Soler R, et al. Among authors: yang ly. Cancer Res. 1988 Aug 15;48(16):4509-12. Cancer Res. 1988. PMID: 3396003

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,053 results

Search Page

Filters